ETFs & MarketsPremiumAstraZeneca Secures Dual FDA Approval: What It Means for Pharma ETFs
AstraZeneca has received official U.S. regulatory approval for two new drug candidates. This development strengthens the company's pipeline and may influence broader sentiment within pharmaceutical-focused exchange-traded funds over the coming days.
Published 14 hours ago
Read more →